The story of Viagra and its creator , copyright, presents a complex picture for cautious investors. While the revolutionary drug initially generated enormous earnings, its patent has expired , leading to competing versions flooding the arena. This reduction in value presents a significant obstacle for copyright and any fund considering a large h… Read More